Brief Article
Copyright ©2010 Baishideng. All rights reserved
World J Gastroenterol. Jan 21, 2010; 16(3): 345-347
Published online Jan 21, 2010. doi: 10.3748/wjg.v16.i3.345
Prevalence of diverticulosis in recurrent Clostridium difficile infection
Michael J Lipp, Odelya E Pagovich, David Rabin, Albert D Min, Brett B Bernstein
Michael J Lipp, Albert D Min, Brett B Bernstein, Division of Digestive Diseases, Beth Israel Medical Center, New York, NY 10003, United States
Odelya E Pagovich, David Rabin, Division of Medicine, Beth Israel Medical Center, New York, NY 10003, United States
Author contributions: Lipp MJ designed the study; Lipp MJ and Pagovich OE performed the chart evaluations and data analysis; Lipp MJ and Rabin D wrote the manuscript; Min AD and Bernstein BB were involved with editing the manuscript.
Correspondence to: Michael J Lipp, MD, Division of Digestive Diseases, Beth Israel Medical Center, 16th Street at 1st Avenue, 17-Baird Hall, New York, NY 10003, United States. mlipp@chpnet.org
Telephone: +1-212-4204183 Fax: +1-646-3493596
Received: September 25, 2009
Revised: October 26, 2009
Accepted: November 1, 2009
Published online: January 21, 2010
Abstract

AIM: To re-evaluate the theory that colonic diverticulosis is associated with relapse of Clostridium difficile associated disease (CDAD) in light of data suggesting increasing rates of CDAD infection and relapse.

METHODS: Charts were reviewed for patients with recurrent CDAD who had also had a prior colonoscopy or flexible sigmoidoscopy. An age and gender matched control group was used to compare the prevalence of diverticulosis.

RESULTS: Twenty-two patients met the study criteria, and the prevalence of diverticulosis in patients with CDAD relapse was 23% compared to 32% in age and sex matched controls (P = 0.44). A significant proportion of patients with CDAD relapse had co-morbidities associated with immune suppression.

CONCLUSION: Diverticulosis does not appear to be associated with CDAD relapse.

Keywords: Clostridium difficile; Diverticulosis; Relapse; Immune suppression; Clostridium difficile associated disease